How medicalized residential care influences care plans for vulnerable palliative patients
Impact of Medicalized Residential Care (LAM) on the Development of Care Plans for Vulnerable Patients in Palliative Care: a Qualitative Study
This study will see if living in a medicalized residential facility in Alsace changes how care plans are made for adults receiving palliative care.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Strasbourg, France Academic / other |
| Locations | 1 site (Strasbourg) |
| Trial ID | NCT07342985 on ClinicalTrials.gov |
What this trial studies
This observational study will include adults (≥18) receiving palliative care who live in one of two medicalized residential care (LAM) regions of Alsace, France. Researchers will collect clinical and contextual information from medical records and care teams to identify factors that influence the development of care plans. The study focuses on vulnerable patients in palliative settings and excludes those who refuse participation. The goal is to describe patterns and drivers of care planning in LAM settings rather than to test a specific treatment.
Who should consider this trial
Good fit: Adults aged 18 or older who reside in one of the two LAM regions of Alsace and are receiving palliative care are the intended participants.
Not a fit: Patients who do not live in the specified LAM regions, who are not in palliative care, or who decline to participate are unlikely to receive direct benefit from this study.
Why it matters
Potential benefit: If successful, the findings could help tailor care plans and improve coordination and quality of end-of-life care for vulnerable patients in medicalized residences.
How similar studies have performed: While structured care-planning approaches have improved outcomes in other palliative settings, studies specifically examining care-plan development in French LAM facilities are limited.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult subject (≥18 years old) * Subject residing in one of the two LAM regions of Alsace (France) at the time of the study and suffering from a palliative-care condition (the nature of the condition (or conditions) is not specified) Exclusion Criteria: \- Refusal to participate in the study
Where this trial is running
Strasbourg
- Service d'Accompagnement et de Soins Palliatifs - CHU de Strasbourg - France — Strasbourg, France (Recruiting)
Study contacts
- Study coordinator: Johanna LAPLACE, MD
- Email: johanna.laplace@chru-strasbourg.fr
- Phone: 33 3 88 11 65 80
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.